CoBX Bio
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $19M
Investors
- 10
About CoBX Bio
Based in Seoul, South Korea, and founded in 2024, CoBX Bio, Inc. operates as a company that researches and develops covalent bond inhibitors and molecular adhesive degraders that can address shortcomings of current synthetic medications, including resistance and insufficient effectiveness, by forming stronger attachments to disease-related proteins. In June 2026, CoBX Bio, Inc. CoBX Bio’s proprietary platform, RaPIDome, integrates chemical proteomics, molecular modeling, and AI to identify drug mechanisms and resistance pathways. Key pipelines include covalent inhibitors targeting Menin (a MEN1-derived protein) and molecular adhesive degraders aimed at GSPT1, a protein linked to cancer cell survival. These compounds are designed to offer enhanced efficacy and resistance mitigation. The company plans to use the September 2025 funds to support the development of Menin inhibitors and E3 ligase inhibitors.
Who invested in CoBX Bio
10 investors across 1 round
See all investors in CoBX Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 30, 2026
Amount
$19M
Investors
Questions about CoBX Bio
Who invested in CoBX Bio?
CoBX Bio has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CoBX Bio raised?
CoBX Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CoBX Bio last raise money?
CoBX Bio's most recent round on record is a Series B, in Jun 2026.
What does CoBX Bio do?
Based in Seoul, South Korea, and founded in 2024, CoBX Bio, Inc.
Where is CoBX Bio headquartered?
CoBX Bio is headquartered in Seoul, South Korea.
Which VCs invest in companies like CoBX Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back companies at CoBX Bio's stage. Their profiles are linked below.
VCs to look at next
Raising like CoBX Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.